Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Expression of active human immunodeficiency virus type 1 protease by noninfectious chimeric virus particles.

Kohl NE, Diehl RE, Rands E, Davis LJ, Hanobik MG, Wolanski B, Dixon RA.

J Virol. 1991 Jun;65(6):3007-14.

3.
5.
8.

Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.

Wu X, Liu H, Xiao H, Kappes JC.

Virology. 1996 May 1;219(1):307-13.

9.

Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.

Kräusslich HG, Ochsenbauer C, Traenckner AM, Mergener K, Fäcke M, Gelderblom HR, Bosch V.

Virology. 1993 Feb;192(2):605-17.

PMID:
8421902
13.
14.

Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.

Mak J, Jiang M, Wainberg MA, Hammarskjöld ML, Rekosh D, Kleiman L.

J Virol. 1994 Apr;68(4):2065-72.

15.

Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.

Cherry E, Liang C, Rong L, Quan Y, Inouye P, Li X, Morin N, Kotler M, Wainberg MA.

J Mol Biol. 1998 Nov 20;284(1):43-56.

PMID:
9811541
16.
17.

Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.

Wu X, Liu H, Xiao H, Conway JA, Hunter E, Kappes JC.

EMBO J. 1997 Aug 15;16(16):5113-22.

18.
20.

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.

zur Megede J, Chen MC, Doe B, Schaefer M, Greer CE, Selby M, Otten GR, Barnett SW.

J Virol. 2000 Mar;74(6):2628-35.

Supplemental Content

Support Center